Tyra Biosciences (TYRA)
(Delayed Data from NSDQ)
$20.22 USD
+0.22 (1.10%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $20.21 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TYRA 20.22 +0.22(1.10%)
Will TYRA be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for TYRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TYRA
Tyra Biosciences (TYRA) Upgraded to Buy: What Does It Mean for the Stock?
Wall Street Analysts See a 27.27% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High?
TYRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Could Help Tyra Biosciences, Inc. (TYRA) Maintain Its Recent Price Strength
Wall Street Analysts Think Tyra Biosciences, Inc. (TYRA) Could Surge 52.22%: Read This Before Placing a Bet
What Makes Tyra Biosciences, Inc. (TYRA) a Good Fit for 'Trend Investing'
Other News for TYRA
Analysts Conflicted on These Healthcare Names: Tyra Bioscience (TYRA), Spruce Biosciences (SPRB) and UnitedHealth (UNH)
Tyra Biosciences to Present at Upcoming Investor Conferences
Buy Rating Affirmed: TYRA-300’s Progress and Potent FGFR3 Inhibition Signal Promising Outcomes for Tyra Bioscience
Tyra Bioscience (TYRA) Gets a Buy from Wedbush
Tyra Biosciences GAAP EPS of -$0.35 beats by $0.11